跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,600 条关于
“soluble amyloid beta oligomers”
全部
14,600
临床试验
11,397
药物
1,205
机构
29
资讯
1,969
去年
Acumen Pharmaceuticals Utilizes pTau217 Assay in Sabirnetug Phase 2 Alzheimer's Trial
去年
Acumen's Sabirnetug Shows Promise in Phase 1 Alzheimer's Trial
去年
Acumen Pharmaceuticals' pTau217 Assay Streamlines Alzheimer's Clinical Trials
10个月前
Acumen Pharmaceuticals Initiates Open-Label Extension Study for Alzheimer's Drug Sabirnetug
去年
ProMIS Neurosciences' PMN310 Shows Promise in Phase 1a Alzheimer's Trial
去年
Acumen Pharmaceuticals Advances Sabirnetug in Alzheimer's Disease Treatment
9个月前
Acumen Pharmaceuticals Demonstrates 68-Fold Increase in Brain Delivery for Alzheimer's Antibody Using Novel Transferrin Receptor Technology
去年
Acumen and Lonza Expand Collaboration to Advance Sabirnetug for Alzheimer's Disease
去年
Acumen and NKGen Present Alzheimer's Research at CTAD 2024
去年
ProMIS Neurosciences' PMN310 Shows Promise in Phase 1a Alzheimer's Trial
第 1 页，共 197 页
上一页
下一页
